Skip to main content
. 2021 Jun 24;12:603997. doi: 10.3389/fphar.2021.603997

FIGURE 1.

FIGURE 1

The proposed scheme on the potential of serratiopeptidase on infection, immunity and inflammation in context to SARS-CoV-2 and on the symptoms of COVID-19.